Kustannus Oy Duodecim

Kustannus Oy Duodecim is a company in Helsinki, Finland that has taken part in 2 EU-funded projects since 2011, receiving €1.0M in EU funding.

EU funding received€1.0M
EU projects2
As coordinator0
Running now0
First EU project2011
Latest project2012
CountryFinland
EU registration (PIC)984524102
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Kustannus Oy Duodecim's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€1.0M · 2 projects

Projects

2 EU-funded projects, newest first. Each links to the official record.

  • PRIMA-EDSPartner

    Polypharmacy in chronic diseases: Reduction of Inappropriate Medication and Adverse drug events in elderly populations by electronic Decision Support

    FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗

    €885ktheir share
  • DECIDEPartner

    Developing and Evaluating Communication strategies to support Informed Decisions and practice based on Evidence

    FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗

    €122ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • adverse drug reactions
  • cardiovascular diseases
  • diabetes
  • pharmaceutical drugs
  • surgery

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime